Trial intelligence / Profile preview

Balanced propofol sedation versus propofol sedation for ERCP in elderly patients

ChiCTR2000039265Phase 4Recruiting

Sponsor
The Second Hospital of Hebei Medical University
Start
Nov 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol, midazolam and nalbuphine in None (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Rate of vasopressor use. Started Nov 2020; status: recruiting.

02

Drugs

propofolmidazolamnalbuphine

Beyond the preview

Go deeper on ChiCTR2000039265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call